<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03659552</url>
  </required_header>
  <id_info>
    <org_study_id>CLN-0012</org_study_id>
    <nct_id>NCT03659552</nct_id>
  </id_info>
  <brief_title>Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access</brief_title>
  <official_title>Feasibility of Using a Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lungpacer Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lungpacer Medical Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study conducted to confirm phrenic nerve stimulation using the a transvenous Phrenic Nerve
      Stimulator in the left jugular vein.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Lungpacer Jugular Access Feasibility System is a prototype for the Lungpacer Diaphragm
      Pacing Therapy System (DPTS) and consists of the LIVE Catheter, a stimulation system with a
      Multipole Panel Accessory, an airflow sensor and a Heart Rate Data Capture Device. The
      catheter is intended for inclusion in the commercial product. The stimulation system with a
      Multipole Panel Accessory and a Heart Rate Data Capture Device is an interim component
      created to enable initial safety and feasibility testing of the Lungpacer DPTS concept.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 7, 2018</start_date>
  <completion_date type="Actual">August 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group assignment</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful insertion of the LIVE Catheter into the left jugular vein and stimulation of phrenic nerves</measure>
    <time_frame>through study completion, an average of 14 days</time_frame>
    <description>To determine whether in an anesthetized (sedated, intubated, and mechanically ventilated) patient the LIVE Catheter can be inserted percutaneously in the left jugular vein and, via the electrical stimulator, to transvenously stimulate one or both phrenic nerves causing the diaphragm to contract</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absence of device related or procedure related adverse events</measure>
    <time_frame>through study completion, an average of 14 days</time_frame>
    <description>Assess subject for adverse events status up to 48 hours post procedure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Tidal volume assessement</measure>
    <time_frame>during the procedure only up to 3 hours</time_frame>
    <description>Generation of tidal volume upon delivery of stimulation to the phrenic nerve(s) without spontaneous or ventilator support, as measured by the ventilator</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Ventilator-Induced Lung Injury</condition>
  <arm_group>
    <arm_group_label>Temporary diaphragmatic pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There is no comparator for this study. Single site and all patients are in the treatment allocated group of temporary diaphragmatic pacing with the LIVE Catheter which is inserted via the left jugular vein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LIVE Catheter</intervention_name>
    <description>Placement of a temporary LIVE Catheter central venous pacing device in the left jugular vein to pace the phrenic nerves and allow recruitment of the diaphragm muscle.</description>
    <arm_group_label>Temporary diaphragmatic pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older;

          -  Able and willing to give informed consent or whose legally authorized representative
             is able and willing to give informed consent;

          -  Able to undergo general anesthesia (sedation, intubation, and mechanical ventilation);

          -  Acceptable indication for atrial septal defect closure.

        Exclusion Criteria:

          -  Subject has an ejection fraction of &lt; 30%

          -  Subject has a co-morbid illness or life expectancy &lt; 2 years

          -  Subject has experienced an acute myocardial infarction within 72 hours prior to this
             procedure

          -  Subject is contraindicated for or unwilling to take aspirin or anticoagulants

          -  Subject is in cardiogenic shock

          -  Subject has other cardiovascular disease requiring open heart surgery

          -  Subject is known to have a demonstrated intra cardiac thrombus on echocardiography

          -  Subject has been treated with paralytic medications within 72 hours prior to procedure

          -  Subject has significant thoracic abnormalities such that placement of a left
             subclavian line would be difficult

          -  Inability to cannulate the left subclavian vein (post-consent exclusion)

          -  Subject has a known or suspected phrenic nerve paralysis

          -  Subject has co-existing temporary or implanted cardiac electrical devices such as a
             pacemaker or defibrillator

          -  Subject has an active systemic infection or local infection at or around the insertion
             site

          -  Subject is known or suspected to be pregnant or is lactating

          -  Subject will be unavailable for, or is unwilling to comply with, follow up
             requirements of the protocol

          -  Subject is currently enrolled in any other study of an investigational drug or device
             who has received treatment under that protocol with the investigational product during
             the 30 days prior to screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda Clark, RN</last_name>
    <role>Study Director</role>
    <affiliation>Lungpacer Medical Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrian Ebner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Italian Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Italian Hospital</name>
      <address>
        <city>Asunción</city>
        <state>Casa Zanotti</state>
        <country>Paraguay</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Paraguay</country>
  </location_countries>
  <reference>
    <citation>Michálek P, Kautznerová D. Combined use of ultrasonography and neurostimulation for therapeutic phrenic nerve block. Reg Anesth Pain Med. 2002 May-Jun;27(3):306-8.</citation>
    <PMID>12016605</PMID>
  </reference>
  <results_reference>
    <citation>Escher DJ, Furman S, Solomon N, Schwedel JB. Transvenous pacing of the phrenic nerves. Am Heart J. 1966 Aug;72(2):283-4.</citation>
    <PMID>5915563</PMID>
  </results_reference>
  <results_reference>
    <citation>Escher DJ, Ashley W, Ertag W, Parker B, Furman S, Robinson G. Clinical control of respiration by transvenous phrenic pacing. Trans Am Soc Artif Intern Organs. 1968;14:192-7.</citation>
    <PMID>4882945</PMID>
  </results_reference>
  <results_reference>
    <citation>Eisele JH, Noble MI, Katz J, Fung DL, Hickey RF. Bilateral phrenic-nerve block in man: technical problems and respiratory effects. Anesthesiology. 1972 Jul;37(1):64-9.</citation>
    <PMID>5050104</PMID>
  </results_reference>
  <results_reference>
    <citation>Aubier M, Murciano D, Lecocguic Y, Viires N, Jacquens Y, Squara P, Pariente R. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985 Aug 15;313(7):420-4.</citation>
    <PMID>3860734</PMID>
  </results_reference>
  <results_reference>
    <citation>Ishii K, Kurosawa H, Koyanagi H, Nakano K, Sakakibara N, Sato I, Noshiro M, Ohsawa M. Effects of bilateral transvenous diaphragm pacing on hemodynamic function in patients after cardiac operations. Experimental and clinical study. J Thorac Cardiovasc Surg. 1990 Jul;100(1):108-14.</citation>
    <PMID>2366549</PMID>
  </results_reference>
  <results_reference>
    <citation>Allen GM, McKenzie DK, Gandevia SC, Bass S. Reduced voluntary drive to breathe in asthmatic subjects. Respir Physiol. 1993 Jul;93(1):29-40.</citation>
    <PMID>8367614</PMID>
  </results_reference>
  <results_reference>
    <citation>Mulvey DA, Aquilina RJ, Elliott MW, Moxham J, Green M. Diaphragmatic dysfunction in neuralgic amyotrophy: an electrophysiologic evaluation of 16 patients presenting with dyspnea. Am Rev Respir Dis. 1993 Jan;147(1):66-71.</citation>
    <PMID>8420434</PMID>
  </results_reference>
  <results_reference>
    <citation>McKenzie DK, Allen GM, Gandevia SC. Reduced voluntary drive to the human diaphragm at low lung volumes. Respir Physiol. 1996 Aug;105(1-2):69-76.</citation>
    <PMID>8897652</PMID>
  </results_reference>
  <results_reference>
    <citation>Oo T, Watt JW, Soni BM, Sett PK. Delayed diaphragm recovery in 12 patients after high cervical spinal cord injury. A retrospective review of the diaphragm status of 107 patients ventilated after acute spinal cord injury. Spinal Cord. 1999 Feb;37(2):117-22.</citation>
    <PMID>10065750</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahn B, Beaver T, Martin T, Hess P, Brumback BA, Ahmed S, Smith BK, Leeuwenburgh C, Martin AD, Ferreira LF. Phrenic nerve stimulation increases human diaphragm fiber force after cardiothoracic surgery. Am J Respir Crit Care Med. 2014 Oct 1;190(7):837-9. doi: 10.1164/rccm.201405-0993LE.</citation>
    <PMID>25271750</PMID>
  </results_reference>
  <results_reference>
    <citation>Germany R, Joseph S, James K, Kao A. A novel therapeutic approach for the treatment of central sleep apnea: The remedē® system. Cardiovasc Revasc Med. 2014 Jun;15(4):235-9. doi: 10.1016/j.carrev.2014.03.007. Epub 2014 Mar 21.</citation>
    <PMID>24726495</PMID>
  </results_reference>
  <results_reference>
    <citation>Linhart M, Nielson A, Andrié RP, Mittmann-Braun EL, Stöckigt F, Kreuz J, Nickenig G, Schrickel JW, Lickfett LM. Fluoroscopy of spontaneous breathing is more sensitive than phrenic nerve stimulation for detection of right phrenic nerve injury during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014 Aug;25(8):859-865. doi: 10.1111/jce.12431. Epub 2014 May 18.</citation>
    <PMID>24724724</PMID>
  </results_reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>May 3, 2018</study_first_submitted>
  <study_first_submitted_qc>September 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2018</study_first_posted>
  <last_update_submitted>September 4, 2018</last_update_submitted>
  <last_update_submitted_qc>September 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Ventilator-Induced Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Lungpacer may at any time publish the results of and information pertaining to the investigation subject only to compliance with regulatory requirements pertaining to patient protected health information</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

